MedTrace Logo

Norepinephrine to Prevent Hypotension in Ceasrean Delivery

NCT05248932 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-10-14

No results posted yet for this study

Summary

This study will be conducted on 40 healthy women having spinal anesthesia for elective cesarean delivery in the operating rooms at Menoufia university hospital.

Conditions

Interventions

DRUG

Norepinephrine bolus

5 microgram bolus therapy

DEVICE

cardiometry

cardiac output, stroke volume and fluid responsiveness monitoring

DRUG

Norepinephrine infusion

2.5 microgram/min infusion

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-20
Primary Completion
2022-05-20
Completion
2022-06-20

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05248932 on ClinicalTrials.gov